<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="helma.xsl"?>
<xmlroot xmlns:hop="http://www.helma.org/docs/guide/features/database">
  <hopobject id="2432" name="Page" prototype="Page" created="1363280116832" lastModified="1542844508193">
  <hop:parent idref="0" prototyperef="Root"/>
    <http_browser>Mozilla/4.0 (compatible; MSIE 6.0; Windows NT 5.1; SV1)</http_browser>
    <lang>en-us</lang>
    <uri>bone-update</uri>
    <http_host>127.0.0.1:8080</http_host>
    <time type="date">21.11.2018 23:55:08 UTC</time>
    <pseudoparent idref="0" prototyperef="Root"/>
    <http_remotehost>127.0.0.1</http_remotehost>
    <hopsession>127.0.0.1hhn8hkb24mgu</hopsession>
    <user>default</user>
    <pvcount type="float">85.0</pvcount>
    <body>Could you ask her to call me? &lt;a href=&quot;http://globalelite.tv/goldpharma-24com-review-b1c8.pdf&quot;&gt;goldpharma-24.com review&lt;/a&gt;  GSK last week received news that the European Medicines Agency (EMA) had agreed to remove the conditional tag and grant full marketing authorisation to Votrient, and Roche will be able to request similar status if the safety data for Erivedge in BCC proves to be positive.
 </body>
    <http_language>en-US,en;q=0.8</http_language>
    <is_xhtml type="boolean">true</is_xhtml>
    <http_referer>http://beagleboard.org/bone-update/edit</http_referer>
  </hopobject>
</xmlroot>
